Intertwined Epidemics: National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993-2009

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Unick, George Jay ^a   Rosenblum, Daniel ^b   Mars, Sarah ^c   Ciccarone, Daniel ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; EPIDEMIC; ETHNICITY; FEMALE; GROUPS BY AGE; HEROIN DEPENDENCE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; ICD-9; MALE; OPIATE ADDICTION; PREDICTION; PRESCRIPTION; SEX DIFFERENCE; TREND STUDY; DRUG OVERDOSE; HOSPITALIZATION; MIDDLE AGED; OPIOID-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; DRUG OVERDOSE; FEMALE; HEROIN; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS; UNITED STATES; YOUNG ADULT;

EID: 84873541197     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054496     Document Type: Article

References (56)

1. Okie S, (2010) A flood of opioids, a rising tide of deaths. N Engl J Med 363: 1981-1985.
2. Courtwright DT (2001) Dark paradise: a history of opiate addiction in America. Cambridge, MA: Harvard University Press. 326 p.
3. Hickman T (2004) The Double Meaning of Addiction. Habitual Narcotic Use and the Logic of Professionalizing Medical Authority in the United States, 1900-1920. In: Tracy SW, Acker CJ, editors. Altering American Consciousness The History of Alcohol and Drug use in the United States, 1800-2000. Amherst: Amherst and Boston University of Massachusetts Press. 182-202.
4. Schneider EC (2008) Smack: heroin and the American city. Philadelphia: University of Pennsylvania Press. 259 p.
5. Volkow ND, McLellan TA, (2011) Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 305: 1346-1347.
6. Warner M, Chen LH, Makuc DM, National Center for Health Statistics (U.S.) (2009) Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. Hyattsville, MD: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. 7 p.
7. CDC (2010) Emergency department visits involving nonmedical use of selected prescription drugs- United States, 2004-2008. MMWR Morb Mortal Wkly Rep 59: 705-709.
8. CDC (2011) Vital signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Morb Mortal Wkly Rep 60: 1487-1492.
9. Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, et al. (2010) Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. Am J Prev Med 38: 517-524.
10. Paulozzi L, (2008) Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf 17: 997-1005.
11. Darke S, Degenhardt L, Mattick RP (2007) Mortality amongst illicit drug users. Cambridge, UK: Cambridge Univ Press. 191 p.
12. Masson CL, Sorensen JL, Batki SL, Okin R, Delucchi KL, et al. (2002) Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend 66: 45-50.
13. Hansen RN, Oster G, Edelsberg J, Woody GE, Sullivan SD, (2011) Economic costs of nonmedical use of prescription opioids. Clin J Pain 27: 194.
14. Landen NG, Shah SL, Lathrop R, Ross-Reichard MG, (2008) Unintentional drug overdose death trends in New Mexico, USA, 1990-2005: combinations of heroin, cocaine, prescription opioids and alcohol. Addiction 103: 126-136.
15. Evans JL, Tsui JI, Hahn JA, Davidson PJ, Lum PJ, et al. (2012) Mortality Among Young Injection Drug Users in San Francisco: A 10-Year Follow-up of the UFO Study. Am J Epidemiol 175: 302-308.
16. Scott G, Thomas SD, Pollack HA, Ray B, (2007) Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003. J Urban Health 84: 292-306.
17. Warner M, Chen L (2009) Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. Hyattsville, MD.
18. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R, (2008) Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA 299: 70-78.
19. Broz D, Ouellet LJ, (2008) Racial and ethnic changes in heroin injection in the United States: implications for the HIV/AIDS epidemic. Drug Alcohol Depend 94: 221-233.
20. Roy É, Arruda N, Bourgois P, (2011) The Growing Popularity of Prescription Opioid Injection in Downtown Montréal: New Challenges for Harm Reduction. Subst Use Misuse 46: 1142-1150.
21. Khosla N, Juon H, Kirk G, Astemborski J, (2011) Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict Behav 36: 1282-7.
22. Peavy KM, Banta-Green CJ, Kingston S, Hanrahan M, Merrill JO, et al. (2012) "Hooked on" Prescription-Type Opiates Prior to Using Heroin: Results from a Survey of Syringe Exchange Clients. J Psychoactive Drugs 44: 259-265.
23. Cicero TJ, Ellis MS, Surratt HL, (2012) Effect of abuse-deterrent formulation of OxyContin. N Engl J Med 367: 187-189.
24. HCUP (1993-2009) Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) Agency for Healthcare Research and Quality.
25. HCUP (1993-2009) Nationwide Inpatient Sample Trends (NIS-Trends) Files. Healthcare Cost and Utilization Project (HCUP) Agency for Healthcare Research and Quality.
26. Barrett M, Hickey K, Coffey R, Levit K (2012) Population Denominator Data for use with the HCUP Databases (Updated with 2010 Population data). Agency for Healthcare Research and Quality.
27. CDC (2010) Unintentional Drug Poisoning in the United States. Issue Brief. Avaiable: http://www.cdc.gov/homeandrecreationalsafety/pdf/poison-issue-brief.pdf. Accessed 10 November 2012.
28. Daly EM (2012) With rise in young painkiller abusers, officials see more heroin overdoses. CaliforniaWatch: Center for Investigative Reporting. Avaiable: http://californiawatch.org/health-and-welfare/rise-young-painkiller-abusers-officials-see-more-heroin-overdoses-17550. Accessed 10 November 2012.
29. Frosch D (2012) Prescription Drug Overdoses Plague New Mexico. New York Times. U.S. Edition ed. Accessed 8 June 2012.
30. Denton JS, Donoghue ER, McReynolds J, Kalelkar MB, (2008) An epidemic of illicit fentanyl deaths in Cook County, Illinois: September 2005 through April 2007. J Forensic Sci 53: 452-454.
31. Semaan S, Fleming P, Worrell C, Stolp H, Baack B, et al. (2011) Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States. Drug Alcohol Depend 118: 100-110.
32. Wang C, Vlahov D, Galai N, Cole SR, Bareta J, et al. (2005) The effect of HIV infection on overdose mortality. AIDS 19: 935-942.
33. Manchikanti L, (2006) Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician 9: 287-321.
34. Manchikanti L, (2007) National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 10: 399-424.
35. United States General Accounting Office (2003) Prescription drugs: OxyContin abuse and diversion and efforts to address the problem: report to congressional committees. Washington, D.C.: United States General Accounting Office. 57 p.
36. IMS Institute for Healthcare Informatics (2011) The Use of Medicines in the United states: Review of 2010 Avaiable: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/IMS%20Institute/Static%20File/IHII_UseOfMed_report.pdf.Accessed 10 November 2012.
37. CDC (2007) Unintentional poisoning deaths-United States, 1999-2004. MMWR Morb Mortal Wkly Rep 56: 93-96.
38. Webster PC, (2012) Oxycodone class action lawsuit filed. CMAJ 184: E345-E346.
39. FDA (2009) Joint Meeting of the Anesthetic Life Support Drugs Advisory Committee (ALSDAC) and Drug Safety & Risk Management Advisory Committee (DSaRM). Avaiable: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/AnestheticAndLifeSupportDrugsAdvisoryCommittee/UCM187629.pdf. Accessed 10 November, 2012.
40. Manchikanti L, Cash KA, Damron KS, Manchukonda R, Pampati V, et al. (2006) Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Pain Physician 9: 215-225.
41. Lankenau SE, Teti M, Silva K, Bloom JJ, Harocopos A, et al. (2011) Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy 23: 37-44.
42. Havens JR, Stoops WW, Leukefeld CG, Garrity TF, Carlson RG, et al. (2009) Prescription opiate misuse among rural stimulant users in a multistate community-based study. Am J Drug Alcohol Abuse 35: 18-23.
43. Ciccarone D, Unick GJ, Kraus A, (2009) Impact of South American heroin on the US heroin market 1993-2004. Int J Drug Policy 20: 392-401.
44. Mars S, Ciccarone D (2012) The Pill-Studded Path: Heroin Initiation East & West; Harm Reduction Conference. Portland, OR. November 2012.
45. Colson J, Helm S, Silverman S, (2012) Office-Based Opioid Dependence Treatment. Pain Physician 15: ES231-226.
46. Kerlikowske RG (2012) Statement of Director Kerlikowske before the Senate Caucus on International Narcotics Control: "Responding to the Prescription Drug Abuse Epidemic".
47. Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA, (2009) Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 20: 131-136.
48. Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, et al. (2005) Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health 82: 303-311.
49. Piper TM, Rudenstine S, Stancliff S, Sherman S, Nandi V, et al. (2007) Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J 4: 3.
50. Galea S, Worthington N, Piper TM, Nandi VV, Curtis M, et al. (2006) Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav 31: 907-912.
51. Albert S, Brason FW, Sanford CK, Dasgupta N, Graham J, et al. (2011) Project Lazarus: community-based overdose prevention in rural North Carolina. Pain medicine 12Suppl 2: S77-85.
52. Walley A (2012) Bistander Overdose Education and Naloxone Distibution in Massachusetts. FDA Public Workshop: September 24, 2009. Avaiable: http://www.fda.gov/drugs/newsEvents/ucm277119.htm. Accessed 10 November, 2012.
53. Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, et al. (2012) Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 44: 241-7.
54. Doe-Simkins M, Walley AY, Epstein A, Moyer P, (2009) Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 99: 788-791.
55. Green TC, Heimer R, Grau LE, (2008) Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction 103: 979-989.
56. CDC (2012) Community-based opioid overdose prevention programs providing naloxone- United States, 2010. MMWR Morb Mortal Wkly 61: 101-105.